Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
486
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

745
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
745
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

512
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-Light-Responsive Fe-Doped Covalent Organic Framework-Functionalized SiO<sub>2</sub> Nanofibrous Membrane for Synergistic Photothermal and Photodynamic Inactivation of Multidrug-Resistant Bacteria.

Pharmaceutics·2026
Same author

From Single-Ion to Integrated Multi-Ion Platforms: Wearable Sweat Sensors for Electrolyte Monitoring.

Biosensors·2026
Same author

Visible-Light-Driven Photoredox-Catalyzed [4 + 2] Annulation of Unsaturated α-Bromocarbonyls with α-Substituted Styrenes.

The Journal of organic chemistry·2026
Same author

Molecular mechanism of MAFB transcriptional activation of PPARD in regulating adipose browning and protecting against vascular endothelial cell injury.

Experimental cell research·2026
Same author

Insights into the function and structure of the R2TP (RUVBL1-RUVBL2-RPAP3-PIH1D1)chaperone complex.

Cell stress & chaperones·2026
Same author

The m6A demethylase FTO suppresses perivascular adipose tissue browning and exacerbates vascular injury via m6A-mediated destabilization of Irx3 mRNA and the IRX3/UCP1 axis.

Atherosclerosis·2026
Same journal

Invaders taking over-Mollusc faunal change in volcanic barrier lakes of the Albertine Rift biodiversity hotspot.

PloS one·2026
Same journal

AI-driven molecular diversification and ligand-based optimization of macitentan derivatives targeting VEGFR1 and endothelin signaling pathways.

PloS one·2026
Same journal

Performance patterns and records in the world aquatics masters championships: Where do the most frequently represented nations among the top-ten masters swimmers come from?

PloS one·2026
Same journal

Modeling diurnal Temperature-Rainfall relationships under multicollinearity using PLS-SEM: A case study of Ghana.

PloS one·2026
Same journal

Organizational culture, social capital, and emergency capacity in primary healthcare institutions: A cross-sectional structural equation modeling study comparing ordinary and older communities.

PloS one·2026
Same journal

Impact of kidney function on the metabolome in the general population.

PloS one·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Machine learning-based risk prediction model for cognitive dysfunction in elderly individuals.

Lei Zhang1, Xuan Xiang1, Wei Chen1

  • 1Department of Geriatrics, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

Plos One
|December 19, 2025
PubMed
Summary
This summary is machine-generated.

Machine learning models can predict cognitive dysfunction in older adults. The Random Forest model, considering factors like age, race, education, diabetes, and depression, showed the best performance for early risk assessment.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.6K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.6K

Area of Science:

  • Gerontology
  • Medical Informatics
  • Computational Biology

Background:

  • Globalisation has increased cognitive dysfunction prevalence in the elderly.
  • Early intervention for cognitive impairment reduces disease burden and costs.
  • Accurate risk assessment tools are needed for timely intervention.

Purpose of the Study:

  • To develop a machine learning (ML)-based risk prediction model for cognitive dysfunction in the elderly.
  • To identify key predictors of cognitive impairment using ML algorithms.
  • To provide a tool for healthcare professionals and patients for effective risk assessment.

Main Methods:

  • 1,325 elderly participants underwent cognitive assessments and blood tests.
  • Risk factors were identified using univariate analysis, logistic regression, LASSO, and Boruta algorithms.
  • Nine ML models were built and evaluated, with SHAP used for interpretation.

Main Results:

  • The Random Forest (RF) model achieved the highest predictive performance (AUC).
  • Key predictors identified by SHAP analysis include age, race, education, diabetes, and depression.
  • Model calibration and decision curves confirmed strong predictive accuracy and clinical utility.

Conclusions:

  • Age, race, education, diabetes, and depression are significant risk factors for cognitive dysfunction.
  • The Random Forest model demonstrated superior predictive capability among the evaluated ML algorithms.
  • The developed model offers a promising tool for early identification and management of cognitive dysfunction.